Scotland · NHS Scotland MSAN
Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials
MSAN(2024)4 · Level 3 · issued 29 Feb 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| resolution date to be confirmed. | Resupply date to be confirmed | — |
| 3. Alternative beta2-agonists for nebulisation remain available, however, they cannot support an | Available — cannot support uplift | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.